Approval · Notice of Compliance 2947 · 2004
CORTROSYN: Notice of Compliance 2947
Issued May 18, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2947
- Date
- May 18, 2004
- Company
- Amphastar Pharmaceuticals IncRancho Cucamonga, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Adrenocortical insufficiency diagnostic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CORTROSYN | 00022381 | Marketed |
Medicinal ingredients
- COSYNTROPIN 0.25 MG per VIAL